Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
9.78
-1.13 (-10.36%)
At close: Oct 13, 2026, 4:00 PM EDT
9.73
-0.05 (-0.51%)
After-hours: Oct 13, 2026, 5:26 PM EDT
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $612.05 million as of October 13, 2026. It is the 12,648th most valuable company in the world and the 2,527th biggest in the United States. Its market cap has increased by 59.22% in one year.
Market Cap
612.05M
Enterprise Value
407.31M
1-Year Change
59.22%
Global Rank
Country Rank
#2,527 United States
Category
ChartMarket Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $612.05M, a decrease of -72.26%. That is a compound annual growth rate of -20.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 612.05M | 14.55% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Achieve Life Sciences | 730.09M |
| Solid Biosciences | 720.02M |
| Lexicon Pharmaceuticals | 718.60M |
| 4D Molecular Therapeutics | 717.07M |
| Avalo Therapeutics | 704.97M |
| MiMedx Group | 698.92M |
| OmniAb | 690.60M |
| Aura Biosciences | 684.97M |